US 11274077
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase
granted A61PA61P7/02
Quick answer
US patent 11274077 (4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase) held by The United States of America Department of Health expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America Department of Health
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P7/02